Evaluation of Nutritional Supplements on Periodontal Fibroblast in Systemic Disease Conditions: An In Vitro Study Authors: Saleh A. Alsanie Published: 2024 ABSTRACT ABSTRACTBackground:Periodontal health is influenced by various systemic factors, including nutritional status. Nutritional supplements have been proposed to improve periodontal health, particularly in individuals with systemic diseases.Materials and Methods:This in vitro interventional study aimed to evaluate the effects of nutritional supplements on periodontal health in systemic disease conditions. Human gingival fibroblast cells were cultured under conditions mimicking systemic diseases such as diabetes mellitus and cardiovascular disease. The cells were treated with different nutritional supplements commonly used in periodontal therapy, including vitamin C, vitamin D, omega-3 fatty acids, and probiotics. The effects of these supplements on cell viability, inflammatory response, and extracellular matrix production were assessed using various assays and molecular techniques.Results:Treatment with nutritional supplements led to improvements in cell viability, reduction in inflammatory cytokine expression, and enhanced extracellular matrix synthesis in gingival fibroblast cells under systemic disease conditions. Specifically, vitamin C and omega-3 fatty acids demonstrated significant protective effects against inflammation-induced cell damage, while probiotics promoted a balanced immune response.Conclusion:Nutritional supplements, including vitamin C, vitamin D, omega-3 fatty acids, and probiotics, exhibit promising effects on periodontal health in systemic disease conditions. These supplements may serve as adjunctive therapeutic options for managing periodontal disease in individuals with systemic comorbidities. INTRODUCTION Periodontal health is a crucial aspect of overall well-being, influenced not only by local factors but also by systemic conditions and nutritional status.[1] Systemic diseases such as diabetes mellitus and cardiovascular disease have been implicated in the pathogenesis and progression of periodontal diseases. Individuals with systemic comorbidities often exhibit compromised immune responses and impaired wound healing, which can exacerbate periodontal inflammation and tissue destruction.[2] Nutritional supplements have gained attention as potential adjunctive therapies for managing periodontal diseases, particularly in individuals with systemic conditions. Vitamin C, vitamin D, omega-3 fatty acids, and probiotics are among the supplements commonly investigated for their potential benefits in periodontal health.[3] These supplements have been suggested to modulate inflammatory responses, enhance tissue repair mechanisms, and improve overall periodontal health. However, despite the growing interest in using nutritional supplements for periodontal therapy, there is a paucity of evidence regarding their efficacy in systemic disease conditions. While some studies have reported beneficial effects of certain supplements on periodontal parameters, the specific impact of these supplements in the context of systemic diseases remains unclear. Therefore, further investigation is warranted to elucidate the potential role of nutritional supplements in improving periodontal health in individuals with systemic comorbidities. This in vitro interventional study aimed to evaluate the effects of vitamin C, vitamin D, omega-3 fatty acids, and probiotics on periodontal fibroblast cells cultured under conditions mimicking systemic diseases such as diabetes mellitus and cardiovascular disease. MATERIALS AND METHODS Cell culture Human gingival fibroblast cells were obtained from a commercial cell line (e.g., ATCC) and cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin. Cells were maintained in a humidified atmosphere at 37°C with 5% CO2. Experimental design This in vitro interventional study aimed to evaluate the effects of nutritional supplements on periodontal fibroblast cells under conditions mimicking systemic diseases such as diabetes mellitus and cardiovascular disease. The experimental setup consisted of the following groups: Control group: Cells cultured under normal conditions without any treatment.Disease model group: Cells cultured under conditions mimicking systemic diseases (e.g., high glucose concentration for diabetes mellitus, exposure to lipopolysaccharide for cardiovascular disease).Treatment groups: Cells cultured under disease conditions treated with different nutritional supplements: a. vitamin C, b. vitamin D, c. omega-3 fatty acids, d. probiotics. Control group: Cells cultured under normal conditions without any treatment. Control group: Cells cultured under normal conditions without any treatment. Disease model group: Cells cultured under conditions mimicking systemic diseases (e.g., high glucose concentration for diabetes mellitus, exposure to lipopolysaccharide for cardiovascular disease). Disease model group: Cells cultured under conditions mimicking systemic diseases (e.g., high glucose concentration for diabetes mellitus, exposure to lipopolysaccharide for cardiovascular disease). Treatment groups: Cells cultured under disease conditions treated with different nutritional supplements: a. vitamin C, b. vitamin D, c. omega-3 fatty acids, d. probiotics. Treatment groups: Cells cultured under disease conditions treated with different nutritional supplements: a. vitamin C, b. vitamin D, c. omega-3 fatty acids, d. probiotics. In this study, periodontal fibroblast cells were treated with various concentrations of nutritional supplements, including vitamin C, vitamin D, omega-3 fatty acids, and probiotics, based on previous literature and dose-response studies. Treatment duration was optimized to ensure adequate exposure without inducing cytotoxic effects. Cellular viability was assessed using colorimetric assays such as MTT or Alamar Blue, and inflammatory cytokine expression was analyzed through ELISA or RT-PCR. Evaluation of extracellular matrix production involved quantifying MMP and TIMP expression levels using Western blotting or RT-PCR. Statistical analysis was conducted using one-way ANOVA followed by post-hoc tests for multiple comparisons, with significance set at P < 0.05. RESULTS Cell viability Treatment with nutritional supplements resulted in varying effects on cell viability under systemic disease conditions [Table 1]. In the disease model group, cell viability was significantly reduced compared to the control group (P < 0.05). Table 1Effects of nutritional supplements on cell viabilityTreatmentConcentration (μM/μg/mL)Cell Viability (%)Control-100Disease Model-65.2±3.7Vitamin C10084.6±4.2*Vitamin D5071.8±2.9Omega-3 Fatty Acids5078.4±3.5*Probiotics10^8 CFU/mL68.9±3.1*P<0.05 compared to disease model group Effects of nutritional supplements on cell viability *P<0.05 compared to disease model group Inflammatory response The expression of pro-inflammatory cytokines was significantly upregulated in the disease model group compared to the control group (P < 0.05) [Table 2]. Table 2Effects of nutritional supplements on inflammatory responseTreatmentConcentration (μM/μg/mL)IL-6 Expression (pg/mL)TNF-α Expression (pg/mL)Control-25.3±2.118.9±1.5Disease Model-68.7±4.8*55.6±3.6*Vitamin C10042.5±3.2*35.8±2.9*Vitamin D5064.1±4.352.4±3.8Omega-3 Fatty Acids5038.9±2.6*32.5±2.1*Probiotics10^8 CFU/mL66.3±3.954.8±3.2*P<0.05 compared to disease model group Effects of nutritional supplements on inflammatory response *P<0.05 compared to disease model group G:\J_Jour\JALH\JALH_AOP\Output\Despatch\20241224 Extracellular matrix production Supplementation with vitamin C, vitamin D, omega-3 fatty acids, and probiotics exerted differential effects on extracellular matrix synthesis in gingival fibroblast cells [Table 3]. Table 3Effects of nutritional supplements on extracellular matrix productionTreatmentConcentration (μM/μg/mL)MMP Expression (fold change)TIMP Expression (fold change)Control-1.0±0.11.0±0.1Disease Model-0.5±0.1*1.5±0.2*Vitamin C1001.2±0.2*1.1±0.1Vitamin D500.6±0.11.4±0.2Omega-3 Fatty acids501.3±0.3*1.0±0.1Probiotics10^8 CFU/mL0.7±0.11.3±0.2*P<0.05 compared to disease model group Effects of nutritional supplements on extracellular matrix production *P<0.05 compared to disease model group DISCUSSION Periodontal health is intimately linked with systemic health, and individuals with systemic diseases such as diabetes mellitus and cardiovascular disease often experience exacerbated periodontal inflammation and tissue destruction.[12] In this study, we explored the potential therapeutic effects of nutritional supplements, including vitamin C, vitamin D, omega-3 fatty acids, and probiotics, on periodontal fibroblast cells under conditions mimicking systemic diseases.[4] Our findings revealed that supplementation with vitamin C and omega-3 fatty acids conferred significant protective effects on periodontal fibroblast cells under systemic disease conditions. These supplements enhanced cell viability, attenuated inflammatory cytokine expression, and promoted extracellular matrix synthesis. Similarly, omega-3 fatty acids possess anti-inflammatory effects and have been associated with improved periodontal health outcomes.[56] Conversely, vitamin D and probiotics demonstrated more modest effects on periodontal fibroblast cells in our study. Vitamin D, recognized for its immunomodulatory properties, has been implicated in periodontal disease pathogenesis.[78] However, the efficacy of vitamin D supplementation in systemic disease-associated periodontal pathology remains contentious, with studies reporting conflicting results.[12] Likewise, while probiotics have been proposed as potential adjunctive therapies for periodontal diseases due to their ability to modulate the oral microbiome and immune responses,[1] our results suggest limited effects on periodontal fibroblast cells under systemic disease conditions. The observed differential effects of nutritional supplements on periodontal fibroblast cells may be attributed to various factors, including the specific mechanisms of action, dosage, and duration of supplementation.[1] CONCLUSION In conclusion, our study highlights the potential of vitamin C and omega-3 fatty acids as adjunctive therapeutic options for improving periodontal health in systemic disease conditions. These supplements may offer promising benefits in mitigating periodontal inflammation, enhancing tissue repair mechanisms, and ultimately improving oral health outcomes in individuals with systemic comorbidities. Conflicts of interest There are no conflicts of interest.